Frontline Treatment of COPD
We dedicate this monograph to the late
Thomas A. Neff (1937 to 1994), our beloved colleague. Tom was a
consummate physician, a great husband and father, and a tremendous
human being. We shall always be enriched by his memory.

Preface
The first edition of Frontline Treatment of COPD has reached more
than 100,000 frontline practitioners. This monograph has been used
extensively in postgraduate education programs for internists, family
practitioners, nurse practitioners, physicians’ assistants,
pharmacists, clinic and office nurses, and respiratory therapists.
Frontline Treatment of COPD has been the subject of Grand
Rounds in several university hospitals and many community hospitals
around the Country. Many of the authors of the first edition have
participated in these continuing medical education programs.
In conjunction with Medical Education Resources, fall programs
held on Saturday mornings have been well attended, and the program,
based upon this monograph has been extremely well received. The
sponsors have also produced a two hour audio tape that carries the
major messages of this monograph.
This monograph was first published in 1996. In view of significant
advances in our understanding of the patho-genesis of COPD, new
developments in pharmacological management and experimental surgical
approaches, it became necessary to produce a second edition. A new
national healthcare initiative, the National Lung Health Education
Program, (NLHEP), aims to involve all primary care practitioners
in the early identification and intervention in COPD. Section M
of this second edition describes the NLHEP and its goals and objectives.
In the past, we learned to treat acute respiratory failure, to
improve the quality and length of life with ambulatory oxygen therapy,
and to increase the horizons of patients suffering advanced respiratory
insufficiency through the development of pulmonary rehabilitation
programs. Now it is time to take a hard look at preventing the progress
of COPD when it is diagnosed in early and often asymptomatic stages.
The Editor
|